932.6 -10.25 (-1.09%)

Related News for ZYDUSLIFE

Zydus Lifesciences gets USFDA nod for generic drug to prevent chest pain in heart patients

 16 Feb 02:51 PM

Zydus Lifesciences Ltd announced on Friday that it has attained final approval from the US health regulatory authority to produce and distribute its generic Isosorbide Mononitrate extended-release tablets. These tablets are utilized for preventing chest pain in patients with specific heart conditions.

Zydus Lifesciences gets USFDA nod for generic cancer treatment capsules

 14 Dec 03:44 PM

Zydus Lifesciences Ltd has received final approval from the USFDA for its generic version of the cancer treatment drug Cyclophosphamide capsules. The approval covers strengths of 25 mg and 50 mg.

Zydus Lifesciences Q4 Results: Consolidated net profit dips 25% to Rs 297 crore

 18 May 03:21 PM

Zydus Lifesciences Ltd reported a 25.36% decline in consolidated net profit at Rs 296.6 crore in the fourth quarter ended March 31, 2023 impacted by impairment of goodwill of a wholly-owned subsidiary. The company, which had posted a consolidated net profit of Rs 397.4 crore in the same quarter of the previous fiscal, said its board has recommended a final dividend of Rs 6 per equity share of Re 1 each, subject to approval of shareholders at the

Buy Zydus Lifesciences, target price Rs 470: JM Financial

 27 Dec 01:22 PM

Zydus Lifesciences Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 42548.00 Crore) operating in Pharmaceuticals sector.